Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023 ...

Eli Lilly and Novo Nordisk will kick off a massive shopping spree in 2025. The two obesity giants will be sitting on cash ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.

Notable decrease seen in South, which had highest prescription rates for Ozempic, Wegovy and other weight loss meds ...

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

Obesity dipped in U.S. adults last year for the first time in more than a decade, research found. That might be due, in part, ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Obesity is down in the US for the first time in a decade. A new study suggests weight-loss drugs may explain why.

MIT engineers have revealed a new gastric balloon design that can inflate on demand to make you feel full before meals.

New research found that some anti-obesity medications such as Wegovy and Zepbound may prompt people to drink less. These ...